81316642-Skills development for the Ghanaian pharmaceutical sector
VO: VgV Vergabeart: Offenes Verfahren Status: Veröffentlicht

Fristen

Fristen
27.05.2025
06.06.2025 12:00 Uhr
06.06.2025 12:01 Uhr

Adressen/Auftraggeber

Auftraggeber

Auftraggeber

Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
993-80072-52
Dag-Hammarskjöld-Weg 1 - 5
65760
Eschborn
Deutschland
DE71A
Friedrich Graf von Westphalen & Partner mbB Rechtsanwälte
giz.ausschreibungen@fgvw.de
+49 69719189012

Angaben zum Auftraggeber

Von einer Bundesbehörde kontrolliertes oder finanziertes öffentliches Unternehmen
Allgemeine öffentliche Verwaltung

Gemeinsame Beschaffung

Beschaffungsdienstleister
Weitere Auskünfte
Rechtsbehelfsverfahren / Nachprüfungsverfahren

Stelle, die Auskünfte über die Einlegung von Rechtsbehelfen erteilt

Zuständige Stelle für Rechtsbehelfs-/Nachprüfungsverfahren

Vergabekammern des Bundes
022894990
Kaiser-Friedrich-Straße 16
53113
Bonn
Deutschland
DEA22
vk@bundeskartellamt.bund.de
+49 2289499-0
+49 2289499-163

Zuständige Stelle für Schlichtungsverfahren

Auftragsgegenstand

Klassifikation des Auftrags
Dienstleistungen

CPV-Codes

85000000-9
79000000-4
Umfang der Beschaffung

Kurze Beschreibung

Access to affordable and high-quality vaccines and medicines is fundamental to ensuring the well-being of any population. Today, Ghana imports 70 % of the pharmaceutical products and 100 % of the vaccines it needs. As in many African nations, this reliance on imported pharmaceutical products is straining both the economy and public health security. The COVID-19 pandemic underscored the vulnerabilities inherent in this dependency, highlighting the importance for self-reliance and resilient healthcare systems.

Ghana is therefore embarking on an ambitious initiative aimed at enhancing local manufacturing capacities for vaccines and medicines to foster availability and accessibility. The pharmaceutical sector has also been identified as an anchor industry for Ghana's industrial transformation and the creation of decent jobs. On the one hand, Ghana"s pharmaceutical industry faces challenges such as cost-intensive procurement of primary products from abroad, a lack of product diversification, high financing costs and a lack of the necessary technologies, technical capacities and skilled workforce. On the other hand, market opportunities are growing and the industry has a strong basis to build on, such as a network of existing local manufacturers, international collaborations for technology transfer, supply, skills development and research, as well as an enabling policy framework. Ghana thus has the potential to become one of the regional vaccine and pharmaceutical manufacturing hubs in Africa.

Building on this momentum, the European Union (EU) and the German Federal Ministry for Economic Cooperation and Development (BMZ) are co-financing the programme "Strengthening the Ghanaian Pharmaceutical Sector with a Focus on Vaccine Production" (PharmaVax Ghana) as part of the Team Europe Initiative (TEI) Manufacturing and Access to Vaccines, Medicines and Health Technologies (MAV+). GIZ is the implementing agency for this EUR33 million technical cooperation programme running from July 2024 to March 2028.
The programme"s specific objective is to ensure that the public and private ecosystems of Ghana"s pharmaceutical industry contribute to more competitive local manufacturing of pharmaceutical products. Within this ecosystem approach, the programme works on strengthening key enablers for efficient and sustainable vaccine and pharmaceutical manufacturing in Ghana. In particular, it focuses on four key result areas (components):
(1) Governance & Regulation: Enhancing the capacities of Ghanaian public actors to effectively govern, coordinate and regulate pharmaceutical and vaccine manufacturing
(2) Skills Development: Institutionalising practice-oriented, gender-responsive skills development measures needed to grow pharmaceutical and vaccine production capacities in Ghana
(3) Research & Development (R&D): Fostering Ghanaian research institutions" applied R&D capacities and industry partnerships to stimulate local innovation in pharmaceutical and vaccine development and manufacturing
(4) Private Sector Development: Enabling Ghanaian pharmaceutical and vaccine manufacturers to comply with good practices, become attractive for international partnerships and grow their business

Ghana"s Ministry of Finance (MoF) is the programme"s political partner, with the Ministry of Trade and Industry (MoTI) and the National Vaccine Institute (NVI) being the key Ghanaian implementing partners. The programme also works in collaboration with the Food and Drugs Authority (FDA), line ministries for health, education and sciences, Ghana"s pharmaceutical manufacturers, private sector associations as well as relevant research and training institutions and it will create linkages with other African, European and international initiatives, research institutions and companies.

GIZ intends to contract a service provider for the implementation of two work packages within component 2 of the PharmaVax Ghana the programme.

Beschreibung der Beschaffung (Art und Umfang der Dienstleistung bzw. Angabe der Bedürfnisse und Anforderungen)

This assignment contributes to the overall objective of the PharmaVax Ghana programme to ensure that the public and private ecosystems of Ghana"s pharmaceutical industry contribute to more competitive local manufacturing of pharmaceutical products. Specifically, the assignment supports the achievement of the specific objectives and indicators related to component 2 on skills development. Component aims to improve access to practice-oriented and gender-responsive training courses on specialized skill sets needed to grow pharmaceutical and vaccine production sector in Ghana. The hypothesis is that pharmaceutical manufacturers can find and hire qualified workers and professionals locally and engage them in a productive and lucrative local pharmaceutical value chain from R&D and production. This is based on the assumption that private sector stakeholders (including manufacturers) will work together in developing and establishing long-term hands-on training opportunities for needed skills sets. Key partners are Ghanaian vocational and higher education training institutions as well as the public and private sector stakeholders of the pharmaceutical manufacturing sector, in particular manufacturers themselves.

The contractor is responsible for the following two work packages and for achieving the corresponding milestones. These work packages fall under component 2 but there are potentials for synergies and thus need for coordination to the other components, as well as to further activities under component 2 implemented by the GIZ team or financing recipients.

Work package A: Vocational training for the pharmaceutical sector

In addition to highly trained and specialist workers, production floor staff such as qualified machine operators as well as maintenance technicians are needed to expand production and ensure effective and efficient operations. The contractor will support the introduction of a formal technical and vocational education and training (TVET) programme in the area of "pharmaceutical manufacturing process technology" (curricula have already been developed). The training is to be implemented to begin with at one training institution in Accra. If demand and resources allow, it might be expanded in the second year to a second training institution, preferably in Kumasi as the second pharmaceutical industrial centre of the country. Key areas include:
1. Preparation of a detailed implementation concept and plan:
2. training institution(s), qualification levels, target groups, entry requirements, cohort sizes, course duration and training modalities
3. Development of a costing model and a financial and institutional sustainability plan, including fees/pricing/stipends, resource mobilization and partnerships etc.
4. Mobilisation of local and international private sector partners for supporting training implementation
5. Identification of school-based and in-company trainers; finalisation of training materials; delivery of technical and didactical trainings of trainers according to national and, where possible, international standards
6. Mobilisation and procurement of equipment, tools and equipment as well infrastructural upgrades of training institution(s)
7. National accreditation of training institutions, international accreditations and certifications where possible
8. Gender-transformative career guidance and course promotion and gender equitable selection of qualified participants
9. Training delivery at training institution(s) and in companies (workplace experience learning); support to trainees, training institutions, participating companies, trainers; Examination of trainees, recognition of prior learning where appropriate; support to the labour market integration of trainees
10. Monitoring, evaluation and learning, including review and adaptation of course contents, materials and delivery approaches for future cohorts; tracing of graduates

Work package B: Higher education and specialist trainings

The contractor will provide technical advice and assistance to develop at least ten required capacity development measures for qualified specialists in the pharmaceutical sector, on a sustainable basis and in collaboration with well-established institutions for higher-education and specialist trainings in Ghana (e.g. Noguchi Memorial Institute for Medical Research, Kumasi Centre for Collaborative Research). Each course shall be run twice with support from the contractor. The subjects of the short courses are to be determined depending on the needs of the pharmaceutical industry in Ghana but could include areas such as vaccine immunology; bacterial genomics and bioinformatics; good laboratory practice; clinical trials management and monitoring; maintenance training on some advanced equipment used in clinical trials; vaccinology; GMP principles in vaccine manufacturing; biopharmaceuticals and biosimilars development, production, analytics; cGMP compliance and consumer safety; cGMP inspection; pharmaceutical validation management; ICH Q9 quality risk Management; ICH 8 and 9; cleaning validation; data integrity and documentation; dossier development; analytical method validation; product quality review; change management and product lifecycle; drug safety and pharmacovigilance; equipment and facility qualification; engineering.

For each course, this includes notably the follow main tasks:
1. Development of course materials together with training institutions and private sector
2. Identification of trainers
3. Set up of infrastructure / Procurement of reagents and equipment
4. Promotion of the course
5. Selection of participants
6. Certification
7. Sustainability concept

Bidders are required to provide 2 key experts (1 team leader and 1 technical expert) as well as expert pools (national and internation expertise). The tender also includes provision of equipment for partners, activities, travel costs for the experts and loclal subcontracts.

Umfang der Auftragsvergabe

EUR

Laufzeit des Vertrags, der Rahmenvereinbarung oder des dynamischen Beschaffungssystems

Laufzeit in Monaten
24

GIZ may optionally commission contract amendments and/or increases based on the criteria in the tender documents to the successful bidder of this tender. For details, please see the terms of reference.

2
Erfüllungsort(e)

Erfüllungsort(e)

Ort im betreffenden Land
Ghana

Weitere Erfüllungsorte

Zuschlagskriterien

Zuschlagskriterien

---
Weitere Informationen

Angaben zu Mitteln der europäischen Union

Angaben zu KMU

Angaben zu Optionen

GIZ may optionally commission contract amendments and/or increases based on the criteria in the tender documents to the successful bidder of this tender. For details, please see the terms of reference.

Zusätzliche Angaben

The contracting authority reserves the right to purchase services consisting of the repetition of similar services entrusted to the undertaking to which the same contracting authority awarded an initial contract, provided that these services are in conformity with a basic project for which the initial contract was awarded. (see Sec. 14 para. 4 no. 9 Public Procurement Regulation).

Verfahren

Verfahrensart

Verfahrensart

Offenes Verfahren

Angaben zum Verfahren

Angaben zum Beschaffungsübereinkommen (GPA)

Besondere Methoden und Instrumente im Vergabeverfahren

Angaben zur Rahmenvereinbarung

Entfällt

Angaben zum dynamischen Beschaffungssystem

Entfällt

Angaben zur elektronischen Auktion

Angaben zur Wiederkehr von Aufträgen

Angaben zur Wiederkehr von Aufträgen

Strategische Auftragsvergabe

Strategische Auftragsvergabe

Klimaschutz
Vermeidung und Verminderung der Umweltverschmutzung
Sonstiges

The tenderer is required to outline in the tender how it can prevent negative impacts on the environment and the climate in its area of responsibility and, in addition, how it can contribute to improving the environmental and climate situation through corresponding measures.

Gleichstellung von ethnischen Gruppen
Gleichstellung der Geschlechter
Fairere Arbeitsbedingungen

The tenderer is required to outline in the tender how it can prevent negative impacts on gender equality in its area of responsibility and how it can contribute to improving gender equality through corresponding measures .

The tenderer is required to outline in the tender how it can prevent negative impacts on the human rights situation in its area of responsibility and how it can contribute to improving the human rights situation through corresponding measures

Gesetz über die Beschaffung sauberer Straßenfahrzeuge

Angaben zu elektronischen Arbeitsabläufen

Angaben zu elektronischen Arbeitsabläufen

Erforderlich
Auftragsunterlagen

Sprache der Auftragsunterlagen

Englisch
Sonstiges / Weitere Angaben

Kommunikationskanal


https://ausschreibungen.giz.de/Satellite/notice/CXTRYY6YTBNR6Z0G

Einlegung von Rechtsbehelfen

According to Article 160, Section 3 of the German Act Against Restraint of Competition (GWB), application for review is not permissible insofar as
1. the applicant has identified the claimed infringement of the procurement rules before submitting the application for review and has not submitted a complaint to the contracting authority within a period of 10 calendar days; the expiry of the period pursuant to Article 134, Section 2 remains unaffected,
2. complaints of infringements of procurement rules that are evident in the tender notice are not submitted to the contracting authority at the latest by the expiry of the deadline for the application or by the deadline for the submission of bids, specified in the tender notice.
3. complaints of infringements of procurement rules that first become evident in the tender documents are not submitted to the contracting authority at the latest by the expiry of the deadline for application or by the deadline for the submission of bids,
4. more than 15 calendar days have expired since receipt of notification from the contracting authority that it is unwilling to redress the complaint.
Sentence 1 does not apply in the case of an application to determine the invalidity of the contract in accordance with Article 135, Section 1 (2). Article 134, Section 1, Sentence 2 remains unaffected.

Frühere Bekanntmachung zu diesem Verfahren

Anwendbarkeit der Verordnung zu drittstaatlichen Subventionen

Zusätzliche Informationen

All communication takes place in English via communication tool in the project area of the procurement portal.

Angebote

Anforderungen an Angebote / Teilnahmeanträge

Sprache(n), in der (denen) Angebote / Teilnahmeanträge eingereicht werden können

Englisch

Varianten / Alternativangebote

Elektronische Kataloge

Nicht zulässig

Mehrere Angebote pro Bieter

Nicht zulässig
Verwaltungsangaben

Bindefrist

147
Tage

Bedingungen für die Öffnung der Angebote

Nachforderung

Eine Nachforderung von Erklärungen, Unterlagen und Nachweisen ist nicht ausgeschlossen.

GIZ asks the applicant or bidder to submit, complete or correct documents, within the framework laid down by law.

Bedingungen

Ausschlussgründe

Ort der Angabe der Ausschlussgründe

Auswahl der Ausschlussgründe

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Please refer to the exclusion criteria §§ 123 and 124 GWB (see tender documents, form Self-declaration of eligibility by tenderers).

Teilnahmebedingungen

Eignungskriterien / Ausschreibungsbedingungen

Eignungskriterium

Referenzen zu bestimmten Dienstleistungen

EN-B1: Technical and professional ability (Mit dem Angebot; Mittels Eigenerklärung): 1. The technical assessment is only based on reference projects with a minimum commission value of 200,000 EUR.
2. At least 3 reference projects in the technical field "skills development in the pharmaceutical sector" and thereof at least 2 reference projects in the region Africa in the above-mentioned technical field in the last 36 months (deadline: date of publication of invitation to tender/EU-publication).

Eignungskriterium

Durchschnittlicher Jahresumsatz

EN-C1: Economic and financial standing (Mit dem Angebot; Mittels Eigenerklärung): Average annual turnover for the last three years (last-but-four financial year can be included in case of tenders held within 6 months of end of last financial year), at least: 2,000,000 EUR.

Eignungskriterium

Andere wirtschaftliche oder finanzielle Anforderungen

EN-B2: Technical and professional ability (Mit dem Angebot; Mittels Eigenerklärung): Average number of employees and managers in the last three calendar years, at least 15 persons.

Eignungskriterium

Eintragung in das Handelsregister

EN-D1:Suitability to pursue the professional activity (Mit dem Angebot; Mittels Eigenerklärung): 1) Extract from the commercial register or equivalent evidence/proof in English or German (not older than six months).

Finanzierung

An advance payment guarantee may be required.

Rechtsform des Bieters

Bedingungen für den Auftrag

Bedingungen für den Auftrag

The execution conditions result from the information given in the contract notice and the tender documents.

Angaben zu geschützten Beschäftigungsverhältnissen

Nein

Angaben zur reservierten Teilnahme

Angaben zur beruflichen Qualifikation

Erforderlich für das Angebot

Angaben zur Sicherheitsüberprüfung